MM&M Awards: Who's Going to Shine in 2009

Share this article:
Despite an increasingly difficult environmental for healthcare marketers, the MM&M Awards program continues to grow in size, stature and relevance—as evidenced by last year's record-breaking 830 submissions. So why such a clamor to win gold? It's because this program is judged fairly, independently and with the authority of a large panel of industry experts. We go to extraordinary lengths to make sure that the best work wins. Just ask a seasoned judge:

“Many areas of marketing communications are highly subjective, more art than science,” says Joe Shields, product director for Enbrel at Wyeth. “However, the judges for the MM&M Awards do their level best to assess fairly entries based on objective criteria and business impact, when provided. I continue to serve as a judge (three times so far) because it is a valuable part of my continuing marketing education. I can count on a few entries each year that make me say, ‘Wow, I wish I had done that!'”
Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"